Butterfly Network Inc (BFLY)vsEdwards Lifesciences Corp (EW)
BFLY
Butterfly Network Inc
$6.37
+4.94%
HEALTHCARE · Cap: $1.71B
EW
Edwards Lifesciences Corp
$102.14
+1.31%
HEALTHCARE · Cap: $52.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 5184% more annual revenue ($6.51B vs $123.25M). EW leads profitability with a 15.4% profit margin vs -43.6%. EW earns a higher WallStSmart Score of 53/100 (C-).
BFLY
Avoid27
out of 100
Grade: F
EW
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BFLY.
Margin of Safety
+68.3%
Fair Value
$250.61
Current Price
$102.14
$148.47 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 51.7% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Strong operational efficiency at 29.8%
Areas to Watch
Trading at 9.2x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 25.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : BFLY
The strongest argument for BFLY centers on Revenue Growth, Debt/Equity. Revenue growth of 51.7% demonstrates continued momentum.
Bull Case : EW
The strongest argument for EW centers on Debt/Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.
Bear Case : BFLY
The primary concerns for BFLY are Price/Book, EPS Growth, Market Cap.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 54.6x leaves little room for execution misses.
Key Dynamics to Monitor
BFLY profiles as a hypergrowth stock while EW is a mature play — different risk/reward profiles.
BFLY carries more volatility with a beta of 2.04 — expect wider price swings.
BFLY is growing revenue faster at 51.7% — sustainability is the question.
EW generates stronger free cash flow (507M), providing more financial flexibility.
Bottom Line
EW scores higher overall (53/100 vs 27/100), backed by strong 15.4% margins and 13.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Butterfly Network Inc
HEALTHCARE · MEDICAL DEVICES · USA
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?